Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Justification for type of information:
This endpoint study record is part of a Weight of Evidence approach comprising of read-across from three analogue source substance studies. The results of the read-across studies agree as to the potential for cytogenicity in mammalian cells and are sufficient to fulfil the information requirements as further explained in the provided genetic toxicity endpoint summary.

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1984

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 473 (In Vitro Mammalian Chromosomal Aberration Test)
Deviations:
yes
Remarks:
no metabolic activation used
GLP compliance:
not specified
Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Chemical structure
Reference substance name:
Glycerol
EC Number:
200-289-5
EC Name:
Glycerol
Cas Number:
56-81-5
Molecular formula:
C3H8O3
IUPAC Name:
Propane-1,2,3-triol
Details on test material:
GLYCERINE USP grade
Specific details on test material used for the study:
Reported as: Glycerin
Purity: 99.4%

Method

Species / strain
Species / strain / cell type:
Chinese hamster lung fibroblasts (V79)
Details on mammalian cell type (if applicable):
The cell line was originally established from the lung of a newborn female at the Cancer Research Institute, Tokyo, and was maintained by 4-day passages in Minimum Essential Medium (MEM; GIBCO) supplemented by 10% calf serum. The modal chromosome number is 25 and the doubling time was approximately 15 hr.
Metabolic activation:
without
Test concentrations with justification for top dose:
up to 1.0 mg/mL
Vehicle / solvent:
Physiological saline
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: Test involved screening a large number of substances, some of which (e.g., hydrogen peroxide, sodium nitrite) gave positive results but no specific positive control as recommended in the guideline was used.
Details on test system and experimental conditions:
METHOD OF APPLICATION: Colcemid (final concentration 0.2 µg/ml) was added to the culture 2 hr before cell harvesting, trypsinized and suspended in a hypotonic KCI solution (0.075 M) for 13 min at room temperature. The cells were centrifuged, fixed with acetic acid-methanol (I :3, v/v) and spread on clean glass slides, air-dried, and stained with Giemsa solution (1.5%, at pH 6.8) for 12-15 min.

DURATION
- Exposure duration: 24 and 48 h

NUMBER OF CELLS EVALUATED: A hundred well-spread metaphases were observed under the microscope (x 600 with a no-cover objective lens).

OTHER EXAMINATIONS:
- Other: The incidence of polyploid cells as well as of cells with structural chromosomal aberrations such as chromatid or chromosome gaps, breaks, exchanges, ring formations, fragmentations and others, was recorded on each culture plate.

OTHER: The cells were exposed to each sample at three different doses
Evaluation criteria:
The results were considered to be negative if the incidence was less than 4.9%, equivocal if it was between 5.0 and 9.9%, and positive if it was more than 10.0%. For a quantitative evaluation of the clastogenic potential, the dose at which structural aberrations (including gaps) were detected in 20% of the metaphases was calculated (D20) along with the frequency of cells with exchange type aberrations per unit dose (mg/mL - TR value). Low TR values indicate low carcinogenic potential in man.

Results and discussion

Test results
Species / strain:
Chinese hamster lung fibroblasts (V79)
Metabolic activation:
without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
Treatment of Chinese hamster lung fibroblasts with SS1 at doses of up to 1.0 mg/mL for a period of either 24- or 48-hours was reported to not increase the frequencies of chromosome aberrations. In the 48-hour exposure experiment, the incidence of structural aberrations and polyploidy was 1.0 and 2.0%, respectively.

Applicant's summary and conclusion

Conclusions:
The authors concluded that the substance was not genotoxic in the in vitro mammalian chromosome aberration assay.